Home > Financial Ratios > GENNEX LABORATORIES

GENNEX LABORATORIES
Core EBITDA Growth

    Back to All Ratios
GENNEX LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 153.7027.91-4.2368.10-12.63

What is the latest Core EBITDA Growth ratio of GENNEX LABORATORIES ?

The latest Core EBITDA Growth ratio of GENNEX LABORATORIES is 153.70 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024153.70
Mar202327.91
Mar2022-4.23
Mar202168.10
Mar2020-12.63

How is Core EBITDA Growth of GENNEX LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 153.7
450.70
Mar2023 27.91
Positive
Mar2022 -4.23
Negative
Mar2021 68.1
Positive
Mar2020 -12.63 -

Other Financial Ratios of GENNEX LABORATORIES


Compare Core EBITDA Growth ratio of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹329.0 Cr 7.3% -22.7% -28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr 2.2% -5.8% 22.9% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 4.1% -7% 52% Stock Analytics
CIPLA ₹116,123.0 Cr 1.3% -4.8% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 2.2% -10.9% -0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 7% -0.2% 27.5% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

7.3%

-22.7%

-28.4%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses